Cardio Diagnostics Holdings, Inc. (CDIO)
$1.87+0.54%Close
SELLRECOVERY · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4M
- Beta
- 2.24
- P/E (TTM)
- -0.68
- Short % float
- 0.05%
- Days to cover
- 1.0
- SI change
- -80.8%
- 1W
- -4.59%
- 1M
- -5.56%
- vs SPY 1W
- -5.75%
- vs SPY 1M
- -8.55%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 1
- VALUE
- 20
- GROWTH
- 4
- GARP
- 5
- TYPE
- Value / Recovery (blended)
Composite of Value · Growth · GARP
ROIC-49.4%
REV YoY-
ROE-82.3%
EPS YoY-
ROA-81.6%
GROSS-555
OP-44691
NET-44772
[VALUATION]
P/E TTM-0.68
P/E FWD-
SECTOR PE20.47
INDUSTRY PE13.95
P/B0.80
P/FCF-
EV/EBITDA-0.11
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E4.98
ALTMAN Z-
CURR RATIO17.15
ND/EBITDA-
BETA2.24
Company news
FAQ
- What is LOPJLB’s current signal on CDIO?
- LOPJLB’s latest quantitative signal on Cardio Diagnostics Holdings, Inc. (CDIO) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is CDIO in?
- Cardio Diagnostics Holdings, Inc. (CDIO) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Cardio Diagnostics Holdings, Inc. (CDIO) do?
- Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was establi…